HIGHLIGHTS
SUMMARY
After binding to their receptors, eCBs are inactivated mainly Advances in Drug and Alcohol Research | Published by Frontiers September 2022 | Volume 2 | Article 10734 CB1 Receptor Agonist Neuroprotects Retina Other studies have verified the protective role of the CB1 and TRPV receptors in glaucoma and retinal ischemia. eCB agonists have being shown to exert a protective role in another model of glaucoma. Membranes were blocked with PBS/ 5% non-fat dry milk and incubated overnight at 4°C with either a rabbit polyclonal antibody to GFAP (DAKO Inc., CA, United_States; Cat #Z0334, dilution 1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.